Popular Diabetes Medication Linked To Kidney Failure Americas Lawyer

Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer

Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer
According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Papantonio: According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Invokana was developed by Janssen, an offshoot of Johnson & Johnson. Unlike other diabete Continue reading

Rate this article

Total 1 ratings

Evidence for Remission of Type 2 Diabetes Symptoms using LCHF

Evidence for Remission of Type 2 Diabetes Symptoms using LCHF
INTRODUCTION: A low carbohydrate, high fatdiet is not new, infacteating this way was the standard recommendation for treating Diabetes prior to the discovery of insulin.
More than 150 years ago, the first weight-loss diet book, written by William Banting, ironically a distant relative of Sir Frederick Banting, the co-discoverer of insulin focused on the limiting the intake of carbohydrates, especially those of a starchy or sugary nature. The book was titled Letter on Corpulence Addressed to the Public (1864) and summarized the advice of the authors physician, Dr. William Harvey that had enabled Banting to shed his portly stature.
In clinical practice, a ketogenic diet (very low carbohydrate, high fat, adequate protein) was successfully used in the Mayo Clinic nearly 100 years ago by Dr. R. Wilderas a treatment for epilepsy and continues to be usedat Johns Hopkins University and other centers for this purpose.
In 1963,Dr. Robert Atkins in his own search for a weight loss plan came across an article in the Journal of the American Medical Association titled A New Concept in the Treatment of Obesity [1]. After he successfullylost weightby following its recommendations, he decided to enroll 20 overweight business executives in a 20 week trial. All lost weight and follow up records indicated that they continued to keep it off for at least a year. After establishing his medical practice in New York City, Dr. Atkins made some adjustments to the plan and incorporated it into his practice, helping his own patients s Continue reading

Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance

Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance
Guidance for 2018 Reflects Expectation of Continued Growth
January 09, 2018 04:15 PM Eastern Standard Time
SAN DIEGO--( BUSINESS WIRE )--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported select, unaudited and preliminary results for the year and quarter ended December 31, 2017.
In comparing the fourth quarter of 2017 to the same period of 2016:
GAAP sales increased to approximately $39 million to $40 million from $28.9 million
Non-GAAP sales increased to approximately $39 million to $40 million from $24.8 million
Pump shipments increased to approximately 7,000 pumps from 4,418 pumps
In comparing the year ended December 31, 2017 to the year ended December 31, 2016:
GAAP sales increased to approximately $106 million to $107 million from $84.2 million
Non-GAAP sales increased to approximately $101 million to $102 million from $88.5 million
Pump shipments increased to approximately 17,100 pumps from 16,938 pumps
Our 2017 momentum culminated in the fourth quarter with high demand for the t:slim X2 Insulin Pump. In addition, our infusion set sales doubled in the fourth quarter compared to last year, resulting from a shift in our business model that we expect will not only bolster our revenue growth in 2018, but also accelerate our path to profitability, said Kim Blicke Continue reading

Diabetes Could Finally Be Cured with Metabolic Surgery

Diabetes Could Finally Be Cured with Metabolic Surgery
Compared to other developed countries, Singapore is almost world champion, said PM Lee about diabetes during the National Day Rally 2017.
During the National Day Rally 2017 , PM Lee mentioned that 1 in 9 Singaporeans has diabetes. His remark Singapore is almost world champion just behind the US shows how serious diabetes is in Singapore. To combat diabetes , PM Lee suggested four simple ways: go for regular medical check-ups, exercise more, eat less and eat healthily , as well as cut down on soft drinks.
To treat diabetes, one needs to control his blood sugar levels in the body. Most people do it by medications, dietary changes and exercise. But, do you know that theres a surgical method to treat diabetes?
We spoke to Dr. Melvin Look to gain more insights about this breakthrough in diabetes treatment.
RS: Hi Dr. Melvin Look. Its a pleasure to meet you. Tell us about yourself!
Dr. Look: I am a Consultant Surgeon at PanAsia Surgery in Mount Elizabeth Hospital. My specialty interest is in Gastrointestinal and Laparoscopic Surgery, and I have also been performing Bariatric Surgery for more than 15 years.
In the early days of Bariatric Surgery our primary objective is in achieving sustainable weight loss for our patients with morbid obesity. Along the way, we also found that these operations can also result in long-term remission of diabetes.
Bariatric Surgery now includes this important aspect of what we call Metabolic Surgery, where we aim to cure obesity-related medical problems (such as diabetes, hypertension Continue reading

Men and Low Testosterone

As the years go by, mens bodies go through certain changes some of them visible, and some of which can only be felt. When a man passes 40 years of age, one of these changes is likely to be a gradual reduction in testosterone production. Most men are loath to talk about it, and they may not even know whats happening to them. But they may complain of having lower strength, gaining weight, and not feeling like myself.
While the interaction between diabetes and testosterone is a topic that could use more studying, existing research makes clear that men with diabetes are more likely to have low testosterone and men with low testosterone are more likely to have diabetes. This article examines the factors that may lead to low testosterone, and outlines some steps you might be able to take to help reverse this process.
Testosterone is the hormone that turns boys into men. It gives you facial hair, puts muscle on your frame, and changes the pitch of your voice. It speeds up the muscle recovery process and creates a sense of strength its probably part of the reason why some men in their 20s feel like they can get away with anything. Its critical to male sexual behavior and reproduction, with additional beneficial effects on bone density and emotional well-being.
Unlike women, men do not experience a sudden drop in hormones as part of the aging process. Testosterone declines gradually, generally starting after age 40. According to a study published in the European Journal of Endocrinology, once this process starts, the typical rate of decline is between 0.5% and 2% per year. T Continue reading